Axsome Therapeutics (AXSM) PT Raised to $185 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Price: $219.38 +1.71%
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $185.00 (from $180.00) while maintaining a Buy rating.
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Bally's Corp (BALY) PT Lowered to $10; Truist Securities: 'Mixed results amidst a "going concern"'
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
